Sientra Inc (NASDAQ:SIEN) rose 12.9% during mid-day trading on Friday . The stock traded as high as $12.43 and last traded at $11.66. Approximately 961,848 shares changed hands during trading, an increase of 240% from the average daily volume of 283,254 shares. The stock had previously closed at $10.33.
SIEN has been the subject of several research reports. BidaskClub downgraded Sientra from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Canaccord Genuity reaffirmed a “buy” rating and set a $19.00 price target on shares of Sientra in a report on Friday, January 5th. Zacks Investment Research raised Sientra from a “sell” rating to a “hold” rating in a report on Tuesday, January 2nd. ValuEngine raised Sientra from a “sell” rating to a “hold” rating in a report on Sunday, December 31st. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $14.00 price target (up previously from $11.00) on shares of Sientra in a report on Wednesday, September 27th. One analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the stock. Sientra presently has a consensus rating of “Buy” and a consensus price target of $15.00.
The stock has a market cap of $226.15, a price-to-earnings ratio of -4.09 and a beta of -1.47. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.92 and a current ratio of 2.87.
Several institutional investors and hedge funds have recently bought and sold shares of SIEN. JPMorgan Chase & Co. acquired a new stake in shares of Sientra during the second quarter worth $101,000. Nationwide Fund Advisors lifted its holdings in shares of Sientra by 260.4% during the second quarter. Nationwide Fund Advisors now owns 10,963 shares of the medical instruments supplier’s stock worth $107,000 after buying an additional 7,921 shares in the last quarter. New York State Common Retirement Fund acquired a new stake in shares of Sientra during the second quarter worth $148,000. Rhumbline Advisers acquired a new stake in shares of Sientra during the second quarter worth $158,000. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Sientra by 23.4% during the second quarter. Dimensional Fund Advisors LP now owns 18,660 shares of the medical instruments supplier’s stock worth $181,000 after buying an additional 3,534 shares in the last quarter. 76.59% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: “Sientra (SIEN) Stock Price Up 12.9%” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3146373/sientra-sien-stock-price-up-12-9.html.
Sientra Company Profile
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.